An open-label phase II study of low-dose thalidomide in androgen-independent prostate cancer

Marcus Drake, Wendy Robson, P Mehta, I Schofield, DE Neal, HY Leung

Research output: Contribution to journalArticle (Academic Journal)

86 Citations (Scopus)
Original languageEnglish
Pages (from-to)822-827
JournalBritish Journal of Cancer
Volume88
Publication statusPublished - 2003

Cite this

Drake, M., Robson, W., Mehta, P., Schofield, I., Neal, DE., & Leung, HY. (2003). An open-label phase II study of low-dose thalidomide in androgen-independent prostate cancer. British Journal of Cancer, 88, 822-827.